Cargando…
Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373487/ https://www.ncbi.nlm.nih.gov/pubmed/21029366 http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x |
_version_ | 1782363349350088704 |
---|---|
author | Watkins, Claire Rukazenkov, Yuri |
author_facet | Watkins, Claire Rukazenkov, Yuri |
author_sort | Watkins, Claire |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4373487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43734872015-04-20 Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) Watkins, Claire Rukazenkov, Yuri J Cell Mol Med Letter to the Editor Blackwell Publishing Ltd 2010-11 2010-11-29 /pmc/articles/PMC4373487/ /pubmed/21029366 http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x Text en © 2010 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd |
spellingShingle | Letter to the Editor Watkins, Claire Rukazenkov, Yuri Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title | Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title_full | Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title_fullStr | Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title_full_unstemmed | Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title_short | Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) |
title_sort | response to ‘clinical outcomes in nsclc patients with egfr mutations: pooled analysis’ (paz-ares et al., j cell mol med. 2010; 14: 51–69) |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373487/ https://www.ncbi.nlm.nih.gov/pubmed/21029366 http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x |
work_keys_str_mv | AT watkinsclaire responsetoclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed2010145169 AT rukazenkovyuri responsetoclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed2010145169 |